Nalaganje...

EPND-12. TYROSINE KINASE INHIBITORS AXITINIB, IMATINIB AND PAZOPANIB ARE SELECTIVELY POTENT IN EPENDYMOMA

Reproducibly effective chemotherapy has yet to be identified for ependymoma (EPN), partly due to a lack of models for preclinical drug screening. Treatment of EPN has therefore changed little over the last 40 years and is essentially limited to surgery and radiation. Recurrence risk is high, particu...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Neuro Oncol
Main Authors: Donson, Andrew, Werner, Elliot, Amani, Vladimir, Griesinger, Andrea, Witt, Davis, Nellan, Anandani, Vibhakar, Rajeev, Hankinson, Todd, Handler, Michael, Dorris, Kathleen, Foreman, Nicholas
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2017
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5475033/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox083.070
Oznake: Označite
Brez oznak, prvi označite!